Literature DB >> 17617831

Syndecan-1 and Wingless-type protein-1 in human ameloblastomas.

P Leocata1, D Villari, C Fazzari, M Lentini, C Fortunato, P A Nicòtina.   

Abstract

BACKGROUND: Aberrant Wingless type 1 glycoprotein (Wnt) pathway in ameloblastomas and a role of syndecan-1 (SDC1) in activating Wnt signalling were perspected. SDC1 shifting from epithelium to stroma was reported in invasive non-odontogenic neoplasms. The aim of this study was to reveal the role of SDC1 and Wnt1 in intraosseous ameloblastomas (IA(s)).
METHODS: SDC1 and Wnt1 expressions were investigated in 29 ameloblastoma subtypes and seven tooth buds.
RESULTS: SDC1 immunostaining strongly depicted stromal cells, extracellular matrix (ECM) and basement membranes of ameloblastomas. It also showed epithelial tumour cells in the acanthomatous and plexiform subtypes, and it often occurred in stellate reticulum cells and basal ameloblasts of tooth buds. Parallel Wnt1 expression occurred in ameloblastomatous epithelial cells, but it was common in basal cells of tooth buds too. Statistically, a significant correlation was found between the percentage of IA(s)-bearing SDC1-positive stromal cells and ECM and the percentage of IA(s)-bearing Wnt1-positive epithelial cells.
CONCLUSIONS: A role of SDC1 in stromal cells and ECM can be hypothesized as a critical factor for carcinogenesis and local invasiveness of IA(s).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617831     DOI: 10.1111/j.1600-0714.2007.00537.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

1.  Focal Adhesion Kinase Expression in Ameloblastoma: A Preliminary Observational Study.

Authors:  Snehal Patil; Gargi Sachin Sarode; Sachin C Sarode; Rahul Anand; Shankargouda Patil
Journal:  J Clin Diagn Res       Date:  2017-06-01

Review 2.  Dually modified transmembrane proteoglycans in development and disease.

Authors:  Laura M Jenkins; Ben Horst; Carly L Lancaster; Karthikeyan Mythreye
Journal:  Cytokine Growth Factor Rev       Date:  2017-12-22       Impact factor: 17.660

Review 3.  Molecular and genetic aspects in the etiopathogenesis of ameloblastoma: An update.

Authors:  Ravleen Nagi; Shashikant Sahu; N Rakesh
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

4.  Immunoexpression of Wnt/β-catenin signaling pathway proteins in ameloblastoma and calcifying cystic odontogenic tumor.

Authors:  Sabrina-Nogueira Dutra; Fábio-Ramôa Pires; Luciana Armada; Rebeca-Souza Azevedo
Journal:  J Clin Exp Dent       Date:  2017-01-01

5.  Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas.

Authors:  Ramón G Carreón-Burciaga; Rogelio González-González; Nelly Molina-Frechero; Sandra López-Verdín; Vanesa Pereira-Prado; Ronell Bologna-Molina
Journal:  Anal Cell Pathol (Amst)       Date:  2018-04-23       Impact factor: 2.916

Review 6.  Proteoglycans as potential biomarkers in odontogenic tumors.

Authors:  Zaira Gómez-Herrera; Nelly Molina-Frechero; Pablo Damián-Matsumura; Ronell Bologna-Molina
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr

7.  Molecular markers of tumor invasiveness in ameloblastoma: An update.

Authors:  Yi Zhong; Wei Guo; Li Wang; Xinming Chen
Journal:  Ann Maxillofac Surg       Date:  2011-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.